GEHC — GE HealthCare Technologies Share Price
Last trade - 00:00- $28.56bn
- $34.88bn
- $19.67bn
- 74
- 48
- 84
- 78
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.85 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -0.97% | ||
| Dividend Yield (f) | 0.29% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.38 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 18.42 | ||
| Price to Sales | 1.45 | ||
| EV to EBITDA | 10.88 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.15% | ||
| Return on Equity | 25.59% | ||
| Operating Margin | 13.34% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 17,164 | 17,585 | 18,341 | 19,552 | 19,672 | 20,026.17 | 20,972.6 | 3.41% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +25.07 | +10.56 | -10.51 | -15.69 | +42.75 | -5.92 | +11.38 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 16th, 2022
- Public Since
- December 15th, 2022
- No. of Shareholders
- 189,289
- No. of Employees
- 53,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 457,843,185
- Address
- 500 West Monroe Street, CHICAGO, 60661
- Web
- https://www.gehealthcare.com
- Phone
- +1 2033604369
- Auditors
- Deloitte & Touche LLP
Latest News for GEHC
Upcoming Events for GEHC
Dividend For GEHC34.SA - 0.0177 BRL
Dividend For GEHC.OQ - 0.0350 USD
Q1 2025 GE Healthcare Technologies Inc Earnings Call
Q1 2025 GE Healthcare Technologies Inc Earnings Release
GE Healthcare Technologies Inc Annual Shareholders Meeting
GE Healthcare Technologies Inc Annual Shareholders Meeting
Q2 2025 GE Healthcare Technologies Inc Earnings Release
Similar to GEHC
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
As of Today at 20:46 UTC, shares in GE HealthCare Technologies are trading at $62.37. This share price information is delayed by 15 minutes.
Shares in GE HealthCare Technologies last closed at $62.37 and the price had moved by -26.79% over the past 365 days. In terms of relative price strength the GE HealthCare Technologies share price has underperformed the S&P500 Index by -31.16% over the past year.
The overall consensus recommendation for GE HealthCare Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe GE HealthCare Technologies dividend yield is 0.19% based on the trailing twelve month period.
Last year, GE HealthCare Technologies paid a total dividend of $0.12, and it currently has a trailing dividend yield of 0.19%.Looking ahead, shares in GE HealthCare Technologies are due to go ex-dividend on 2025-04-25 and the next dividend pay date is 2025-05-15.
GE HealthCare Technologies are due to go ex-dividend on 2025-04-25 and the next dividend pay date is 2025-05-15. The historic dividend yield on GE HealthCare Technologies shares is currently 0.19%.
To buy shares in GE HealthCare Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $62.37, shares in GE HealthCare Technologies had a market capitalisation of $28.56bn.
Here are the trading details for GE HealthCare Technologies:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: GEHC
Based on an overall assessment of its quality, value and momentum GE HealthCare Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in GE HealthCare Technologies is $99.03. That is 58.78% above the last closing price of $62.37.
Analysts covering GE HealthCare Technologies currently have a consensus Earnings Per Share (EPS) forecast of $4.69 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GE HealthCare Technologies. Over the past six months, its share price has underperformed the S&P500 Index by -24.33%.
As of the last closing price of $62.37, shares in GE HealthCare Technologies were trading -25.51% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The GE HealthCare Technologies PE ratio based on its reported earnings over the past 12 months is 12.85. The shares last closed at $62.37.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on GE HealthCare Technologies' directors